Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 2011

View Archived Issues

Tamsulosin OCAS plus solifenacin in BPH-associated LUTS: SATURN results disclosed at EAU meeting

Marine product NPM-01 has neuroprotective activity

Chloroquine inhibits pancreatic tumor growth by suppressing autophagy

Researchers at the MCG Research Institute present novel modulators of F1F0 ATP synthase

Nektar begins phase I trial of NKTR-181 for the treatment of pain

European Commission approves Jevtana for second-line treatment of prostate cancer

FDA approves IND for StarGen, a novel ocular product for Stargardt's disease

Galanin GAL1 receptor agonists developed by High Point Pharmaceuticals for pain

Gilenya gains approval in Europe for multiple sclerosis

Janssen discloses novel inhibitors of fatty-acid amide hydrolase

Merck & Co. patents new mGlu2 receptor agonists for schizophrenia

Merck & Co. prepares new series of PDE10A inhibitors

S*BIO's SB-939 to enter advanced lung cancer trials in Singapore

Mucosis begins phase I study of FluGEM vaccine

Hunter Immunology begins phase IIb study of HI-164OV oral vaccine in COPD

CHMP recommends approval of Eliquis for prevention of venous thromboembolic events

EMA committee recommends new pediatric indication for Pfizer's Revatio

Curemark achieves enrollment target for phase III trials of autism therapy CM-AT

CHMP adopts positive opinion on ViroPharma's Cinryze

Photocure's Cevira PDT to be assessed in phase II trial

NanoViricides reports survival data from latest animal study of FluCide drug candidates

FDA clears Insmed's IND for phase III Arikace trial in mycobacterial lung infections

Medicago begins U.S. phase I trial of H1N1 influenza vaccine candidate

PAI-039 improves symptoms of inflammation in experimental model of chronic asthma

Calcitriol activity may prevent steroid-resistant asthma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...